Adriaan Kooy

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Diabetes, obesity & metabolism

BMJ open

Pharmaceuticals (Basel, Switzerland)

University Medical Center Groningen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center Groningen Jan 17o 2017

Netherlands

Associate Professor :: Internal Medicine and Vascular Medicine

Publications

Taha Sen, Viktor Rotbain Curovic, Niels Jongs, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Ellen Burgess, Hiddo J Lambers Heerspink
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials. Diabetes, obesity & metabolism (2023)
Viktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, Niels Jongs, Emilie H Zobel, Tine Willum Hansen, Juliette Tavenier, Jesper Eugen-Olsen, Gozewijn D Laverman, Adriaan Kooy, Frederik Persson, Ellen Burgess, Hiddo J Lambers Heerspink
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes. Diabetes, obesity & metabolism (2023)
Wiebe M C Top, Philippe Lehert, Casper G Schalkwijk, Coen D A Stehouwer, Adriaan Kooy
Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial. Diabetes, obesity & metabolism 24 (10) (2022)
Wiebe M C Top, Adriaan Kooy, Coen D A Stehouwer
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Eline G M van Hoorn, Peter Ruben van Dijk, Jelmer R Prins, Helen L Lutgers, Klaas Hoogenberg, Jan Jaap H M Erwich, Adriaan Kooy
Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus. BMJ open 12 (3) (2022)
Avivit Cahn, Stephen D Wiviott, Lawrence A Leiter, Sabina A Murphy, Erica L Goodrich, Ilan Yanuv, Aliza Rozenberg, John P H Wilding, Lawrence Alan Leiter, Deepak L Bhatt, Darren K McGuire, Leon Litwak, Adriaan Kooy, Ingrid A M Gause-Nilsson, Martin Fredriksson, Anna Maria Langkilde, Marc S Sabatine, Itamar Raz
Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58. Diabetes, obesity & metabolism 23 (1) (2020)
Kåre I Birkeland, Johan Bodegard, Anna Norhammar, Josephina G Kuiper, Elena Georgiado, Wendy L Beekman-Hendriks, Marcus Thuresson, Marc Pignot, Ron M C Herings, Adriaan Kooy
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes, obesity & metabolism 21 (4) (2019)
Mattijs Out, Wiebe M C Top, Philippe Lehert, Casper A Schalkwijk, Coen D A Stehouwer, Adriaan Kooy
Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial. Diabetes, obesity & metabolism 20 (8) (2018)
Mattijs Out, Ida Miedema, Harriët Jager-Wittenaar, Cees van der Schans, Wim Krijnen, Philippe Lehert, Coen D A Stehouwer, Adriaan Kooy
Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial. Diabetes, obesity & metabolism 20 (1) (2017)
Wiebe Top, Coen D A Stehouwer, Philippe Lehert, Adriaan Kooy
Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial. Diabetes, obesity & metabolism 20 (3) (2017)

Adriaan Kooy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adriaan Kooy